Frontiers in Neurology (Dec 2021)

Preventing Ischemic Cerebrovascular Events in High-Risk Patients With Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning: A Single-Arm Study

  • Shimeng Liu,
  • Shimeng Liu,
  • Zongen Gao,
  • Ran Meng,
  • Haiqing Song,
  • Tianping Tang,
  • Ya Zhao,
  • Rong Chen,
  • Yanzhen Sheng,
  • Qianqian Fan,
  • Fang Jiang,
  • Qian Zhang,
  • Jianping Ding,
  • Xiaoqin Huang,
  • Qingfeng Ma,
  • Kai Dong,
  • Sufang Xue,
  • Zhipeng Yu,
  • Jiangang Duan,
  • Changbiao Chu,
  • Xiaohui Chen,
  • Xingquan Huang,
  • Sijie Li,
  • Bruce Ovbiagele,
  • Wenle Zhao,
  • Xunming Ji,
  • Xunming Ji,
  • Xunming Ji,
  • Xunming Ji,
  • Xunming Ji,
  • Xunming Ji,
  • Xunming Ji,
  • Xunming Ji,
  • Wuwei Feng,
  • Wuwei Feng

DOI
https://doi.org/10.3389/fneur.2021.748916
Journal volume & issue
Vol. 12

Abstract

Read online

Background: Secondary stroke prevention after a high-risk, non-disabling ischemic cerebrovascular event needs to be enhanced. The study was conducted to investigate whether remote ischemic conditioning (RIC) is effective in preventing recurrent ischemic events within 3 months.Methods: This was a four-center, single-arm, open-label Phase IIa futility trial (PICNIC-One Study). Adult patients (≥18 years of age) who had an acute minor ischemic stroke (AMIS) with a National Institutes of Health Stroke Scale score ≤ 3 or a transient ischemic attack (TIA) with moderate-to-high risk of stroke recurrence (ABCD score ≥ 4) within 14 days of symptom onset were recruited. Patients received RIC as adjunctive therapy to routine secondary stroke prevention regimen. RIC consisted of five cycles of 5-min inflation (200 mmHg) and 5-min deflation of cuffs (45 min) on bilateral upper limbs twice a day for 90 days.Results: A total of 285 patients met the study criteria, of which 167 provided signed informed consent and were enrolled. Data from 162 were analyzed with five subjects excluded. Recurrent AIS/TIA occurred in 6/162 (3.7%) patients within 3 months, with no occurrence of hemorrhagic stroke. The top three adverse events were upper limb pain (44/162, 27.2%), petechia (26/162, 16.0%), and heart palpitation (5/162, 3.1%). About 68 (42.0%) subjects completed ≥ 50% of 45-min RIC sessions.Conclusions: RIC is a safe add-on procedure and it has a potential benefit in reducing recurrent cerebrovascular events in patients with high-risk, non-disabling ischemic cerebrovascular events as the risk of stroke/TIA events is lower than expected; however, its compliance needs to be improved. Our study provides critical preliminary data to plan a large sample size, randomized controlled clinical study to systematically investigate the safety and efficacy of RIC in this population.

Keywords